Steve Mister

CRN’s New FDA Warning Letters Database Helps Industry Self-Police

Companies can reference warning letters to learn what not to do, the association says.

News

Celebrating DSHEA, with Caution

Celebrations are shadowed by suspicions that some are treading on the law.

Article

JAMA Finds Spiked Supplements Still on the Market after FDA Recalls

Two-thirds of dietary supplement products recalled by FDA remained on the market with adulterated substances, according to JAMA.

News

“It’s a Truly Sad Day.” Has the FTC Gone Too Far?

In response to the Bayer Phillips’ Colon Health case, the dietary supplement industry says the agency’s substantiation bar is too high.

Article

Weight-Loss Cases Spark Highest FTC Settlement Costs

But questionable antiaging and diabetes claims are also on the rise.

News

Advice for the Next Head of FDA’s Division of Dietary Supplements

Two industry leaders offer advice to the next head of FDA’s Division of Dietary Supplements—whoever she or he may be.

Article
Photo ©iStockphoto.com

What Will It Take to Stop Sketchy Weight-Loss Ads?

It's not FTC action alone.

Article

Negative Multivitamin Stories Make News, CRN Stresses Multivitamin Benefits

Overall, the study results were largely inconclusive against disease prevention.

News

A Non-DMAA World: The Status of DMAA in Today's Dietary Supplements Market

Has FDA effectively slammed the door shut on DMAA?

Article

Negative Dietary Supplement Report from the Department of Health and Human Services

Will a new, negative Department of Health and Human Services report follow the dietary supplements industry for years?

Article
Syndicate content